Ara&#250;jo NC Barton V Jones M Stocks PA Ward SA Davies J Bray PG Shone AE Cristiano ML O'Neill PM Semi-synthetic and synthetic 1,2,4-trioxaquines and 1,2,4-trioxolaquines: synthesis, preliminary SAR and comparison with acridine endoperoxide conjugates Bioorg Med Chem Lett 2009 19 2038-2043 
Atamna H Ginsburg H The malaria parasite supplies glutathione to its host cell: investigation of glutathione transport and metabolism in human erythrocytes infected with Plasmodium falciparum Eur J Biochem 1997 250 670-679 
Barends M Jaidee A Khaohirun N Singhasivanon P Nosten F In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border Malar J 2007 6 81 
Basco LK Dechy-Cabaret O Ndounga M Meche FS Robert A Meunier B In vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates Antimicrob Agents Chemother 2001 45 1886-1888 
Becker K Rahlfs S Nickel C Schirmer RH Glutathione: functions and metabolism in the malarial parasite Plasmodium falciparum Biol Chem 2003 384 551-566 
Bejon P Lusingu J Olotu A Leach A Lievens M Vekemans J Mshamu S Lang T Gould J Dubois MC Demoitie MA Stallaert JF Vansadia P Carter T Njuguna P Awuondo KO Malabeja A Abdul O Gesase S Mturi N Drakeley CJ Savarese B Villafana T Ballou WR Cohen J Riley EM Lemnge MM Marsh K von Seidlein L Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age N Engl J Med 2008 359 2521-2532 
Benoit-Vical F Lelievre J Berry A Deymier C Dechy-Cabaret O Cazelles J Loup C Robert A Magnaval JF Meunier B Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes Antimicrob Agents Chemother 2007 51 1463-1472 
Biot C Dessolin J Ricard I Dive D Easily synthesized antimalarial ferrocene triazacyclononane quinoline conjugates J Organomet Chem 2004 689 4678-4682 
Biot C Pradines B Sergeant MH Gut J Rosenthal PJ Chibale K Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues Bioorg Med Chem Lett 2007 17 6434-6438 
Bloland PB Drug resistance in malaria 2001 Geneva WHO, Malaria Epidemiology Branch, Centers for Disease Control and Prevention 1-23 
Bray PG Martin RE Tilley L Ward SA Kirk K Fidock DA Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance Mol Microbiol 2005 56 323-333 
Burgess SJ Selzer A Kelly JX Smilkstein MJ Riscoe MK Peyton DH A chloroquine-like molecule designed to reverse resistance in Plasmodium falciparum J Med Chem 2006 49 5623-5625 
Capela R Oliveira R Goncalves LM Domingos A Gut J Rosenthal PJ Lopes F Moreira R Artemisinin-dipeptidyl vinyl sulfone hybrid molecules: design, synthesis and preliminary SAR for antiplasmodial activity and falcipain-2 inhibition Bioorg Med Chem Lett 2009 19 3229-3232 
Chipeleme A Gut J Rosenthal PJ Chibale K Synthesis and biological evaluation of phenolic Mannich bases of benzaldehyde and (thio)semicarbazone derivatives against the cysteine protease falcipain-2 and a chloroquine resistant strain of Plasmodium falciparum Bioorg Med Chem 2007 15 273-282 
Chiyanzu I Clarkson C Smith PJ Lehman J Gut J Rosenthal PJ Chibale K Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives Bioorg Med Chem 2005 13 3249-3261 
Cosl&#233;dan F Fraisse L Pellet A Guillou F Mordmuller B Kremsner PG Moreno A Mazier D Maffrand JP Meunier B Selection of a trioxaquine as an antimalarial drug candidate Proc Natl Acad Sci USA 2008 105 17579-17584 
Creek DJ Charman WN Chiu FCK Prankerd RJ Dong Y Vennerstrom JL Charman SA Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials Antimicrob Agents Chemother 2008 52 1291-1296 
Davioud-Charvet E Delarue S Biot C Schw&#246;bel B Boehme CC M&#252;ssigbrodt A Maes L Sergheraert C Grellier P Schirmer RH Becker K A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline J Med Chem 2001 44 4268-4276 
Eckstein-Ludwig U Webb RJ Van Goethem ID East JM Lee AG Kimura M O'Neill PM Bray PG Ward SA Krishna S Artemisinins target the SERCA of Plasmodium falciparum Nature 2003 424 957-961 
Ellis GL Amewu R Hall C Rimmer K Ward SA O'Neill PM An efficient route into synthetically challenging bridged achiral 1,2,4,5-tetraoxanes with antimalarial activity Bioorg Med Chem Lett 2008 18 1720-1724 
Foley M Tilley L Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents Pharmacol Ther 1998 79 55-87 
Gautam A Ahmed T Batra V Paliwal J Pharmacokinetics and pharmacodynamics of endoperoxide antimalarials Curr Drug Metab 2009 10 289-306 
G&#243;mez ZM Rathod PK Antimalarial activity of a combination of 5-fluoroorotate and uridine in mice Antimicrob Agents Chemother 1990 34 1371-1375 
Jones M Mercer AE Stocks PA La Pensee LJ Cosstick R Park BK Kennedy ME Piantanida I Ward SA Davies J Bray PG Rawe SL Baird J Charidza T Janneh O O'Neill PM Antitumour and antimalarial activity of artemisinin-acridine hybrids Bioorg Med Chem Lett 2009 19 2033-2037 
Kelly JX Smilkstein MJ Cooper RA Lane KD Johnson RA Janowsky A Dodean RA Hinrichs DJ Winter R Riscoe M Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum Antimicrob Agents Chemother 2007 51 4133-4140 
Kelly JX Smilkstein MJ Brun R Wittlin S Cooper RA Lane KD Janowsky A Johnson RA Dodean RA Winter R Hinrichs DJ Riscoe MK An efficient route into synthetically challenging bridged achiral 1,2,4,5-tetraoxanes with antimalarial activity Nature 2009 459 270-273 
Kouznetsov VV G&#243;mez-Barrio A Recent developments in the design and synthesis of hybrid molecules based on aminoquinoline ring and their antiplasmodial evaluation Eur J Med Chem 2009 44 3091-3113 
Loup C Lelievre J Benoit-Vical F Meunier B Trioxaquines and heme-artemisinin adducts inhibit the in vitro formation of hemozoin better than chloroquine Antimicrob Agents Chemother 2007 51 3768-3770 
Maher B Malaria: the end of the beginning Nature 2008 451 1042-1046 
Maude RJ Woodrow CJ White LJ The artemisinin antimalarials: preserving the &#8220;magic bullet.&#8221; Drug Dev Res 2010 71 12-19 (this issue)
Meierjohann S Walter RD Muller S Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum Biochem J 2002 368 761-768 
Meshnick SR Yang YZ Lima V Kuypers F Kamchonwongpaisan S Yuthavong Y Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu) Antimicrob Agents Chemother 1993 37 1108-1114 
Morphy R Rankovic Z Designed multiple ligands. An emerging drug discovery paradigm J Med Chem 2005 48 6523-6543 
Muregi FW Kano S Kino H Ishih A Plasmodiumberghei: efficacy of 5-fluoroorotate in combination with commonly used antimalarial drugs in a mouse model Exp Parasitol 2009 121 376-380 
Noedl H Se Y Schaecher K Smith BL Socheat D Fukuda MM Evidence of artemisinin-resistant malaria in western Cambodia N Engl J Med 2008 359 2619-2620 
Nzila A The past, present and future of antifolates in the treatment of Plasmodium falciparum infection J Antimicrob Chemother 2006 57 1043-1054 
Nzila A Ward SA Marsh K Sims PF Hyde JE Comparative folate metabolism in humans and malaria parasites (part I): pointers for malaria treatment from cancer chemotherapy Trends Parasitol 2005 21 292-298 
Olliaro P Wells TN The global portfolio of new antimalarial medicines under development Clin Pharmacol Ther 2009 85 584-595 
Olson JE Lee GK Semenov A Rosenthal PJ Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors Bioorg Med Chem 1999 7 633-638 
Pandey AV Tekwani BL Singh RL Chauhan VS Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite J Biol Chem 1999 274 19383-19388 
Perry CS Charman SA Prankerd RJ Chiu FC Dong Y Vennerstrom JL Charman WN Chemical kinetics and aqueous degradation pathways of a new class of synthetic ozonide antimalarials J Pharm Sci 2006 95 737-747 
Pukrittayakamee S Chotivanich K Chantra A Clemens R Looareesuwan S White NJ Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria Antimicrob Agents Chemother 2004 48 1329-1334 
Raji&#263; Z Kos G Zorc B Singh PP Singh S Macromolecular prodrugs. XII. Primaquine conjugates: synthesis and preliminary antimalarial evaluation Acta Pharm 2009 59 107-115 
Rathod PK G&#243;mez ZM Plasmodiumyoelii: oral delivery of 5-fluoroorotate to treat malaria in mice Exp Parasitol 1991 73 512-514 
Rathod PK Khatri A Hubbert T Milhous WK Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro Antimicrob Agents Chemother 1989 33 1090-1094 
Rathod PK Leffers NP Young RD Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum Antimicrob Agents Chemother 1992 36 704-711 
Robert A Meunier B Is alkylation the main mechanism of action of the antimalarial drug artemisinin? Chem Soc Rev 1998 27 273-279 
Rosenthal PJ Antimalarial drug discovery: old and new approaches J Exp Biol 2003 206 3735-3744 
Sabbani S Stocks PA Ellis GL Davies J Hedenstrom E Ward SA O'Neill PM Piperidine dispiro-1,2,4-trioxane analogues Bioorg Med Chem Lett 2008 18 5804-5808 
Sajid M McKerrow JH Cysteine proteases of parasitic organisms Mol Biochem Parasitol 2002 120 1-21 
Solomon VR Haq W Smilkstein M Srivastava K Rajakumar S Puri SK Katti SB Synthesis and antimalarial activity of novel side chain modified antimalarial agents derived from 4-aminoquinoline Med Chem 2008 4 446-456 
Uhlemann AC Wittlin S Matile H Bustamante LY Krishna S Mechanism of antimalarial action of the synthetic trioxolane RBX11160 (OZ277) Antimicrob Agents Chemother 2007 51 667-672 
Vangapandu S Sachdeva S Jain M Singh S Singh PP Kaul CL Jain R 8-quinolinamines and their pro prodrug conjugates as potent blood-schizontocidal antimalarial agents Bioorg Med Chem 2003 11 4557-4568 
Van Schalkwyk DA Egan TJ Quinoline-resistance reversing agents for the malaria parasite Plasmodium falciparum Drug Resist Updat 2006 9 211-226 
Vennerstrom JL Arbe-Barnes S Brun R Charman SA Chiu FC Chollet J Dong Y Dorn A Hunziker D Matile H McIntosh K Padmanilayam M Santo Tomas J Scheurer C Scorneaux B Tang Y Urwyler H Wittlin S Charman WN Identification of an antimalarial synthetic trioxolane drug development candidate Nature 2004 430 900-904 
Wang X Dong Y Wittlin S Creek D Chollet J Charman SA Tomas JS Scheurer C Snyder C Vennerstrom JL Spiro- and dispiro-1,2-dioxolanes: contribution of iron(II)-mediated one-electron vs two-electron reduction to the activity of antimalarial peroxides J Med Chem 2007 50 5840-5847 
Wei N Sadrzadeh SM Enhancement of hemin-induced membrane damage by artemisinin Biochem Pharmacol 1994 48 737-741 
Wiwanitkit V Plasmodium and host glutathione reductase: molecular function and biological process Afr J Biotechnol 2006 5 2009-2013 
Zhou L Alker A Ruf A Wang X Chiu FC Morizzi J Charman SA Charman WN Scheurer C Wittlin S Dong Y Hunziker D Vennerstrom JL Characterization of the two major CYP450 metabolites of ozonide (1,2,4-trioxolane) OZ277 Bioorg Med Chem Lett 2008 18 1555-1558 
